Mode
Text Size
Log in / Sign up
Phase 4 N=288

COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study

Colorectal Surgery

Enrolled (actual)
288
Serious AEs
9.3%
Results posted
Oct 2013
Primary outcome: Primary: To Evaluate Rate of Anastomotic Leaks Related to the Use of the ColonRing™ Device, at 1 Month

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
ColonRing (Colorectal anastomosis) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
novoGI
Primary completion
Jul 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
To Evaluate Rate of Anastomotic Leaks Related to the Use of the ColonRing™ Device, at 1 Month
PRIMARY
Device Related Leak Rate up to 30 Days Post op
4
SECONDARY
Rate of Other Device Related Complications and Other Parameters During Hospitalization and Post Procedure.

Summary

The performance of the ColonRing™ will be comparable to or better than the reported performance of staplers.

Eligibility Criteria

Inclusion Criteria

  • Subject is ≥ 18 years old.
  • BMI < 34.
  • Subject is planned to undergo a non-emergency (i.e., elective) operation with the creation of an anastomosis using the ColonRing™.
  • Subject signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures.

Exclusion Criteria

  • Subject has a known allergy to nickel.
  • Subject is planned to undergo an emergency procedure or has a diagnosis of bowel strangulation, peritonitis, bowel perforation, local or systemic infection, ischemic bowel,carcinomatosis.
  • Subject has participated in another clinical study which may affect this study's outcomes within the last 30 days.
  • Subject's ASA (American Society of Anesthesiology) score 4 or 5.
  • Subject has a concurrent or previous invasive pelvic malignancy.
  • Subject has a systemic or incapacitating disease.
  • Subject has extensive local disease in the pelvis.
  • Subject requires more than one anastomosis during the surgery.
  • Women who are known to be pregnant.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01091155). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search